We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
10 Year Est. Return
AUM
$368M
AUM Growth
+$240M
Cap. Flow
+$255M
Cap. Flow %
69.4%
Top 10 Hldgs %
25.49%
Holding
710
New
414
Increased
42
Reduced
13
Closed
237

Sector Composition

Rank Sector Weight
1 Financials 24.48%
2 Healthcare 11.95%
3 Technology 8.6%
4 Industrials 8.02%
5 Energy 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNCR icon
451
Xencor
XNCR
$1.6B
$70.6K 0.02%
+6,634
New +$110K
ANNX icon
452
Annexon
ANNX
$883M
$70.3K 0.02%
+36,399
New +$121K
SLN
453
Silence Therapeutics
SLN
$729M
$70.1K 0.02%
+24,872
New +$121K
BCYC
454
Bicycle Therapeutics
BCYC
$288M
$69.3K 0.02%
+8,162
New +$96.2K
TERN
455
DELISTED
Terns Pharmaceuticals
TERN
$68.8K 0.02%
+24,913
New +$102K
DYN icon
456
Dyne Therapeutics
DYN
$4.95B
$67.1K 0.02%
+6,413
New +$91.7K
CRVS icon
457
Corvus Pharmaceuticals
CRVS
$1.16B
$64.6K 0.02%
+20,315
New +$95.7K
TECX
458
Tectonic Therapeutic
TECX
$639M
$62.7K 0.02%
+3,541
New +$115K
MBX
459
MBX Biosciences
MBX
$3.19B
$59.1K 0.02%
+8,006
New +$84.6K
ARVN icon
460
Arvinas
ARVN
$588M
$58.4K 0.02%
+8,318
New +$130K
LRMR icon
461
Larimar Therapeutics
LRMR
$417M
$57.8K 0.02%
+26,869
New +$84.9K
THRD
462
DELISTED
Third Harmonic Bio
THRD
$50.6K 0.01%
+14,593
New +$70.8K
CRGX
463
DELISTED
CARGO Therapeutics
CRGX
$44.7K 0.01%
+10,988
New +$73.6K
TALO icon
464
Talos Energy
TALO
$2.6B
$28.9K 0.01%
2,973
IGMS
465
DELISTED
IGM Biosciences
IGMS
$23K 0.01%
+19,974
New +$37.1K
PLRX icon
466
Pliant Therapeutics
PLRX
$64.4M
$16K ﹤0.01%
+11,850
New +$71.9K
NMRA icon
467
Neumora Therapeutics
NMRA
$300M
$15.5K ﹤0.01%
+15,516
New +$26.6K
SCLX icon
468
Scilex Holding
SCLX
$47.1M
$4.24K ﹤0.01%
+513
New +$6.44K
SD icon
469
SandRidge Energy
SD
$531M
$1.82K ﹤0.01%
+159
New +$1.89K
AAPL icon
470
Apple
AAPL
$4.5T
-8,208
Closed -$2.06M
AB icon
471
AllianceBernstein
AB
$3.45B
-15,000
Closed -$556K
ABBV icon
472
AbbVie
ABBV
$438B
-44
Closed -$7.82K
ABM icon
473
ABM Industries
ABM
$2.81B
-4,600
Closed -$235K
ACA icon
474
Arcosa
ACA
$7.11B
-5,700
Closed -$551K
ACM icon
475
Aecom
ACM
$9.42B
-10,627
Closed -$1.14M

Similar funds

Virtus Investment Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Virtus Investment Advisers held 710 positions worth $368M, up 188% from $128M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Virtus Investment Advisers deployed $255M of net new capital in Q1 2025, opening 414 new positions and adding to 42 existing holdings. Its largest new stake was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Berry Corp, an estimated $666K trimmed.

  • Virtus Investment Advisers's largest Q1 2025 buy was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.
  • Virtus Investment Advisers added most to Yum China in Q1 2025, an estimated $1.42M increase.
  • Virtus Investment Advisers's biggest Q1 2025 reduction was Berry Corp, cutting an estimated $666K.
  • Virtus Investment Advisers fully exited ICICI Bank in Q1 2025, selling an estimated $3.75M.
  • Virtus Investment Advisers's ten largest holdings make up 25% of its $368M portfolio in Q1 2025.
  • Virtus Investment Advisers opened 414 new positions and closed 237 in Q1 2025.
  • Virtus Investment Advisers's portfolio value rose 188% quarter-over-quarter to $368M.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.